MBII

Stats

Summary

Marrone Bio Innovations Inc.  is a growth-oriented company leading the movement to a more sustainable world through the discovery, development and sale of innovative biological products for crop protection and plant health that help customers operate more sustainably while increasing their return on investment. MBI has screened over 18,000 microorganisms, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies and natural product chemistry to rapidly develop seven product lines. Supported by a robust portfolio of over 500 issued and pending patents, MBI's currently available commercial products are Regalia®, Stargus®, Grandevo®, Venerate®, Majestene®, Haven®, Pacesetter®, Zelto® Jet-Oxide® and Jet-Ag® , with a next-generation insecticide-nematicide, a breakthrough bioherbicide and a biofumigant in the Company's product pipeline. MBI's Pro Farm Finland-based subsidiary employs a proprietary technology derived from wood waste to stimulate plant growth and improve plant health, resulting in improved yields and crop quality. Products include UBP™ 110, Foramin®, UBP™ Seed Treatment, Foramin® ST.

Market Cap: 182 Million

Primary Exchange: NASDAQ

Website: www.marronebioinnovations.com

Shares Outstanding: 182 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 0.7761129594067269

Sector: Manufacturing

Industry: Pesticide and Other Agricultural Chemical Manufacturing

Ethical Flags

Longest drawdown: 2478 trading days

From: 2013-10-18 To: 2022-07-12

Lowest Point: